Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 959-967

  Weiss, Glen J ^a   Hoff, Brandi R ^a   Whitehead, Robert P ^a   Sangal, Ashish ^a   Gingrich, Susan A ^a   Penny, Robert J ^b   Mallery, David W ^b   Morris, Scott M ^b   Thompson, Eric J ^b   Loesch, David M ^b   Khemka, Vivek ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

^b Paradigm Diagnostics   (United States)

Author keywords

Assay; Cancer; Next generation sequencing; Platform; Treatment decision making

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; BREAST CARCINOMA; CANCER TISSUE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; DECISION MAKING; DEMOGRAPHY; ENDOMETRIUM CARCINOMA; EVALUATION STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; INDEL MUTATION; INTERMETHOD COMPARISON; KIDNEY CANCER; LEIOMYOSARCOMA; LUNG ADENOCARCINOMA; MALE; MESOTHELIOMA; NEXT GENERATION SEQUENCING; ONCOLOGY; OVARY CARCINOMA; SOFT TISSUE SARCOMA; SOLID TUMOR; SOMATIC MUTATION; TREATMENT RESPONSE;

EID: 84929430264     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S81995     Document Type: Article

References (14)

1. Bailey CH, Jameson G, Sima C, et al. Progression-free survival decreases with each subsequent therapy in patients presenting for phase I clinical trials. J Cancer. 2012;3:7–13.
2. MacConaill LE. Existing and emerging technologies for tumor genomic profiling. J Clin Oncol. 2013;31(15):1815–1824.
3. Von Hoff DD, Stephenson JJ, Rosen P, et al. Pilot study using molecular profiling of patients’ tumors to find potential targets and select treatments for their refractory cancers. J Clin Oncol. 2010;28(33):4877–4883.
4. Roychowdhury S, Iyer MK, Robinson DR, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med. 2011;3(111):111ra121.
5. Tran B, Brown AMK, Bedard PL, et al. Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial. Int J Cancer. 2013;132(7):1547–1755.
6. Weiss GJ, Liang WS, Demeure MJ, et al. A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges. PLoS One. 2013;8(10):e76438.
7. Servant N, Roméjon J, Gestraud P, et al. Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial. Front Genet. 2014;5:152.
8. Frampton GM, Fichtenholtz A, Otto GA, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023–1031.
9. US Food and Drug Administration. [Webpage on the Internet]. Hematology/Oncology (Cancer) Approvals & Safety Notifications. Available from http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm. Accessed December 3, 2015.
10. Gray SW, Hicks-Courant K, Cronin A, Rollins BJ, Weeks JC. Physicians’ attitudes about multiplex tumor genomic testing. J Clin Oncol. 2014;32(13):1317–1323.
11. Vignot S, Frampton GM, Soria JC, et al. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J Clin Oncol. 2013;31(17):2167–2172.
12. Tsongalis GJ, Peterson JD, de Abreu FB, et al. Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations. Clin Chem Lab Med. 2014;52(5):707–714.
13. Leighl NB, Rekhtman N, Biermann WA, et al. Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline. J Clin Oncol. 2014;32(32):3673–3679.
14. Genomeweb.com [homepage on the Internet]. New York: GenomeWeb; 2015. Available from: https://www.genomeweb.com/clinical-genomics/belgiums-oncodna-sequence-1300-patients-under-breast-international-groups-aurora. Accessed February 21, 2015.